Magnus Grönberg, Author at Inify Laboratories

Inify Laboratories AB (publ) – kommuniké från årsstämma

Swedish news 2024-05-15

Inify Laboratories AB, org. nr. 559345-4431, har den 14 maj 2024 hållit årsstämma i företagets lokaler. Totalt var 30 133 104 aktier representerade på bolagsstämman, vilket motsvarar 66,61 % av det […]

Inify Laboratories AB (publ) – summary of Annual General Meeting

Annual General Meeting, Investor News 2024-05-15

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 14, 2024. A total of 30,133,104 shares were represented at the […]

Inify Laboratories – Fler diagnoser levererade under första kvartalet än under hela 2023

Finansiella rapporter, Swedish news 2024-04-24

STOCKHOLM – 24 april 2024 – Inify Laboratories, en unik laboratorieverksamhet som tillhandahåller cancerdiagnostik inom patologi, ökade försäljningen med 184% under Q1 2024, jämfört med föregående kvartal. ”Det vi ser […]

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24

STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24

STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]

Inify Laboratories – kallelse till årsstämma den 14 maj 2024

Swedish news 2024-04-11

Stockholm – 11 April, 2024 – Inify Laboratories AB (publ), Inify Laboratories, en unik laboratorieverksamhet som tillhandahåller cancerdiagnostik inom patologi, kallar härmed sina aktieägare till årsstämma den 14 maj 2024. […]

Inify Laboratories – notice of Annual General Meeting on May 14, 2024

Annual General Meeting, Investor News 2024-04-11

Stockholm – April 11, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]

Inify Laboratories – Årsredovisning 2023

Årsredovisningar, Finansiella rapporter, Swedish news 2024-04-11

Stockholm – 11 April, 2024 – Inify Laboratories, en unik laboratorieverksamhet som tillhandahåller cancerdiagnostik inom patologi, presenterar sin årsredovisning för räkenskapsåret som avslutades den 31 december 2023. Årsredovisningen bifogas detta […]

Inify Laboratories – Annual Report 2023

Annual reports, Financial reports, Investor News 2024-04-11

Stockholm – April 11, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2023. […]

Panel talk about Inify’s fourth quarter 2023

Investor News 2024-03-05

Inify Laboratories saw important pieces fall into place during the fourth quarter of 2023, the foremost being the attainment of accreditation as a medical laboratory. This paved the way for […]

Inify Laboratories AB (publ) – kommuniké från årsstämma

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories – Fler diagnoser levererade under första kvartalet än under hela 2023

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Inify Laboratories – kallelse till årsstämma den 14 maj 2024

Inify Laboratories – notice of Annual General Meeting on May 14, 2024

Inify Laboratories – Årsredovisning 2023

Inify Laboratories – Annual Report 2023

Panel talk about Inify’s fourth quarter 2023

Our services

Inify Laboratories

For Investors

Contact us

Social media